{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T02:06:58Z","timestamp":1771294018322,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402377"],"award-info":[{"award-number":["82402377"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515110703, 2022A1515220135"],"award-info":[{"award-number":["2021A1515110703, 2022A1515220135"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010606"],"award-info":[{"award-number":["2023A1515010606"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515220071, 2022A1515011470"],"award-info":[{"award-number":["2021A1515220071, 2022A1515011470"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangzhou Planned Project of Science and Technology","award":["2024A03J1025"],"award-info":[{"award-number":["2024A03J1025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01789-9","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:22:20Z","timestamp":1751361740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MRI proton density fat fraction for estimation of biological characteristics in hepatocellular carcinoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Yingying","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorui","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yidong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"1789_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1789_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases. Hepatology. 2018;68:723\u201350.","journal-title":"Hepatology"},{"key":"1789_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fmed.2017.00193","volume":"4","author":"SN Martins-Filho","year":"2017","unstructured":"Martins-Filho SN, Paiva C, Azevedo RS, Alves VAF. Histological grading of hepatocellular Carcinoma-A systematic review of literature. Front Med (Lausanne). 2017;4:193.","journal-title":"Front Med (Lausanne)"},{"key":"1789_CR4","doi-asserted-by":"crossref","unstructured":"Yan Y, Si Z, Chun C, et al. Multiphase MRI-Based radiomics for predicting histological grade of hepatocellular carcinoma. J Magn Reson Imaging; 2024.","DOI":"10.1002\/jmri.29289"},{"key":"1789_CR5","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.1007\/s00330-020-07601-2","volume":"31","author":"HH Chong","year":"2021","unstructured":"Chong HH, Yang L, Sheng RF, et al. Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma <\/= 5 cm. Eur Radiol. 2021;31:4824\u201338.","journal-title":"Eur Radiol"},{"key":"1789_CR6","doi-asserted-by":"crossref","unstructured":"Yao LQ, Chen ZL, Feng ZH, et al. Clinical features of recurrence after hepatic resection for Early-Stage hepatocellular carcinoma and Long-Term survival outcomes of patients with recurrence: A Multi-institutional analysis. Ann Surg Oncol; 2022.","DOI":"10.14701\/ahbps.2022S1.EP-20"},{"key":"1789_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1479-5876-7-110","volume":"7","author":"MF Zhang","year":"2009","unstructured":"Zhang MF, Zhang ZY, Fu J, Yang YF, Yun JP. Correlation between expression of p53, p21\/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma. J Transl Med. 2009;7:110.","journal-title":"J Transl Med"},{"key":"1789_CR8","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.acra.2023.07.019","volume":"31","author":"Y Yan","year":"2024","unstructured":"Yan Y, Lin XS, Ming WZ, et al. Radiomic analysis based on Gd-EOB-DTPA enhanced MRI for the preoperative prediction of Ki-67 expression in hepatocellular carcinoma. Acad Radiol. 2024;31:859\u201369.","journal-title":"Acad Radiol"},{"key":"1789_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12880-024-01204-9","volume":"24","author":"Y Liang","year":"2024","unstructured":"Liang Y, Xu F, Mou Q, et al. A Gadoxetic acid-enhanced MRI-based model using LI-RADS v2018 features for preoperatively predicting Ki-67 expression in hepatocellular carcinoma. BMC Med Imaging. 2024;24:27.","journal-title":"BMC Med Imaging"},{"key":"1789_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000513704","volume":"10","author":"SB Hong","year":"2021","unstructured":"Hong SB, Choi SH, Kim SY, et al. MRI features for predicting microvascular invasion of hepatocellular carcinoma: A systematic review and Meta-Analysis. Liver Cancer. 2021;10:94\u2013106.","journal-title":"Liver Cancer"},{"key":"1789_CR11","doi-asserted-by":"publisher","first-page":"e220531","DOI":"10.1148\/radiol.220531","volume":"306","author":"A Kitao","year":"2023","unstructured":"Kitao A, Matsui O, Zhang Y, et al. Dynamic CT and Gadoxetic Acid-enhanced MRI characteristics of P53-mutated hepatocellular carcinoma. Radiology. 2023;306:e220531.","journal-title":"Radiology"},{"key":"1789_CR12","doi-asserted-by":"crossref","unstructured":"Kubale R, Schneider G, Lessenich CPN, et al. Ultrasound-Derived fat fraction for hepatic steatosis assessment: prospective study of agreement with MRI PDFF and sources of variability in a heterogeneous population. AJR Am J Roentgenol; 2024.","DOI":"10.2214\/AJR.23.30775"},{"key":"1789_CR13","doi-asserted-by":"publisher","first-page":"8974","DOI":"10.1007\/s00330-023-09864-x","volume":"33","author":"PA Kupczyk","year":"2023","unstructured":"Kupczyk PA, Kurt D, Endler C, et al. MRI proton density fat fraction for Estimation of tumor grade in steatotic hepatocellular carcinoma. Eur Radiol. 2023;33:8974\u201385.","journal-title":"Eur Radiol"},{"key":"1789_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/hep.29762","volume":"68","author":"M Ziol","year":"2018","unstructured":"Ziol M, Pote N, Amaddeo G, et al. Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance. Hepatology. 2018;68:103\u201312.","journal-title":"Hepatology"},{"key":"1789_CR15","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jhep.2019.02.023","volume":"70","author":"X Xu","year":"2019","unstructured":"Xu X, Zhang HL, Liu QP, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol. 2019;70:1133\u201344.","journal-title":"J Hepatol"},{"key":"1789_CR16","doi-asserted-by":"publisher","first-page":"943942","DOI":"10.3389\/fonc.2022.943942","volume":"12","author":"C Wu","year":"2022","unstructured":"Wu C, Chen J, Fan Y, et al. Nomogram based on CT radiomics features combined with clinical factors to predict Ki-67 expression in hepatocellular carcinoma. Front Oncol. 2022;12:943942.","journal-title":"Front Oncol"},{"key":"1789_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jso.21109","volume":"98","author":"PL Tseng","year":"2008","unstructured":"Tseng PL, Tai MH, Huang CC, et al. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients. J Surg Oncol. 2008;98:349\u201357.","journal-title":"J Surg Oncol"},{"key":"1789_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00330-010-1905-5","volume":"21","author":"AE Bohte","year":"2011","unstructured":"Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol. 2011;21:87\u201397.","journal-title":"Eur Radiol"},{"key":"1789_CR19","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.transproceed.2015.10.068","volume":"48","author":"HJ Chiang","year":"2016","unstructured":"Chiang HJ, Chang WP, Chiang HW, et al. Magnetic resonance spectroscopy in Living-Donor liver transplantation. Transpl Proc. 2016;48:1003\u20136.","journal-title":"Transpl Proc"},{"key":"1789_CR20","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1007\/s00330-019-06072-4","volume":"29","author":"J Gu","year":"2019","unstructured":"Gu J, Liu S, Du S, et al. Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis. Eur Radiol. 2019;29:3564\u201373.","journal-title":"Eur Radiol"},{"key":"1789_CR21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1053\/j.gastro.2017.06.005","volume":"153","author":"MS Middleton","year":"2017","unstructured":"Middleton MS, Heba ER, Hooker CA, et al. Agreement between magnetic resonance imaging proton density fat fraction measurements and Pathologist-Assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology. 2017;153:753\u201361.","journal-title":"Gastroenterology"},{"key":"1789_CR22","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1148\/radiol.2020192230","volume":"295","author":"S Mule","year":"2020","unstructured":"Mule S, Galletto Pregliasco A, Tenenhaus A, et al. Multiphase liver MRI for identifying the Macrotrabecular-Massive subtype of hepatocellular carcinoma. Radiology. 2020;295:562\u201371.","journal-title":"Radiology"},{"key":"1789_CR23","doi-asserted-by":"publisher","first-page":"100380","DOI":"10.1016\/j.jhepr.2021.100380","volume":"3","author":"R Cannella","year":"2021","unstructured":"Cannella R, Dioguardi Burgio M, Beaufrere A, et al. Imaging features of histological subtypes of hepatocellular carcinoma: implication for LI-RADS. JHEP Rep. 2021;3:100380.","journal-title":"JHEP Rep"},{"key":"1789_CR24","doi-asserted-by":"publisher","first-page":"110356","DOI":"10.1016\/j.ejrad.2022.110356","volume":"153","author":"Y Liang","year":"2022","unstructured":"Liang Y, Xu F, Wang Z, et al. A Gadoxetic acid-enhanced MRI-based multivariable model using LI-RADS v2018 and other imaging features for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma. Eur J Radiol. 2022;153:110356.","journal-title":"Eur J Radiol"},{"key":"1789_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jhep.2020.08.013","volume":"74","author":"H Rhee","year":"2021","unstructured":"Rhee H, Cho ES, Nahm JH, et al. Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications. J Hepatol. 2021;74:109\u201321.","journal-title":"J Hepatol"},{"key":"1789_CR26","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1002\/jmri.29052","volume":"59","author":"J Cheng","year":"2024","unstructured":"Cheng J, Li X, Wang L, et al. Evaluation and prognostication of Gd-EOB-DTPA MRI and CT in patients with Macrotrabecular-Massive hepatocellular carcinoma. J Magn Reson Imaging. 2024;59:2071\u201381.","journal-title":"J Magn Reson Imaging"},{"key":"1789_CR27","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.crad.2022.05.018","volume":"77","author":"X Liang","year":"2022","unstructured":"Liang X, Shi S, Gao T. Preoperative Gadoxetic acid-enhanced MRI predicts aggressive pathological features in LI-RADS category 5 hepatocellular carcinoma. Clin Radiol. 2022;77:708\u201316.","journal-title":"Clin Radiol"},{"key":"1789_CR28","doi-asserted-by":"crossref","unstructured":"Feng B, Wang L, Zhu Y, et al. The Value of LI-RADS and Radiomic Features From MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma within 5\u00a0cm. Acad Radiol; 2024.","DOI":"10.1016\/j.acra.2023.12.007"},{"key":"1789_CR29","doi-asserted-by":"publisher","first-page":"1021570","DOI":"10.3389\/fonc.2022.1021570","volume":"12","author":"X Yang","year":"2022","unstructured":"Yang X, Shao G, Liu J, et al. Predictive machine learning model for microvascular invasion identification in hepatocellular carcinoma based on the LI-RADS system. Front Oncol. 2022;12:1021570.","journal-title":"Front Oncol"},{"key":"1789_CR30","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ejrad.2015.03.002","volume":"84","author":"JH Min","year":"2015","unstructured":"Min JH, Kim YK, Lim S, Jeong WK, Choi D, Lee WJ. Prediction of microvascular invasion of hepatocellular carcinomas with Gadoxetic acid-enhanced MR imaging: impact of intra-tumoral fat detected on chemical-shift images. Eur J Radiol. 2015;84:1036\u201343.","journal-title":"Eur J Radiol"},{"key":"1789_CR31","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.prp.2017.03.002","volume":"213","author":"L Zhou","year":"2017","unstructured":"Zhou L, Rui JA, Zhou WX, Wang SB, Chen SG, Qu Q. Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio. Pathol Res Pract. 2017;213:824\u201330.","journal-title":"Pathol Res Pract"},{"key":"1789_CR32","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.3748\/wjg.v9.i9.1946","volume":"9","author":"K Liu","year":"2003","unstructured":"Liu K, He X, Lei XZ, et al. Pathomorphological study on location and distribution of Kupffer cells in hepatocellular carcinoma. World J Gastroenterol. 2003;9:1946\u20139.","journal-title":"World J Gastroenterol"},{"key":"1789_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/PAI.0000000000000840","volume":"29","author":"AG Abdou","year":"2021","unstructured":"Abdou AG, Holah NS, Elazab DS, El-Gendy WG, Badr MT, Al-Sharaky DR. Hepatocellular carcinoma score and subclassification into aggressive subtypes using immunohistochemical expression of p53, beta-Catenin, CD133, and Ki-67. Appl Immunohistochem Mol Morphol. 2021;29:20\u201333.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"1789_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1590\/S0036-46652004000100005","volume":"46","author":"VA Alves","year":"2004","unstructured":"Alves VA, Nita ME, Carrilho FJ, et al. p53 immunostaining pattern in Brazilian patients with hepatocellular carcinoma. Rev Inst Med Trop Sao Paulo. 2004;46:25\u201331.","journal-title":"Rev Inst Med Trop Sao Paulo"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01789-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01789-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01789-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:22:23Z","timestamp":1751361743000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01789-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1789"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01789-9","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"20 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Guangzhou First people\u2019s hospital approved this retrospective single-center study with a waiver of informed consent. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"221"}}